Clinical outcomes of BRAF plus MEK inhibition in melanoma: A meta-analysis and systematic review

Cancer Medicine
Qingliang YuLiang Liao

Abstract

Melanoma is a potentially fatal malignancy with poor prognosis. Several recent studies have demonstrated that combination therapy of BRAF and MEK inhibition achieved better curative effect and appeared less toxic effects. We conducted a meta-analysis to evaluate the efficacy and safety between BRAF inhibition plus MEK inhibition combination therapy and BRAF inhibition monotherapy in melanoma patients. We performed the search in PubMed, EMBASE, and the Cochrane Library from January 2010 to January 2019. Inclusion and exclusion of studies, assessment of quality, outcome measures, data extraction, and synthesis were independently accomplished by two reviewers. Revman 5.3 software was used for the meta-analysis. Totally, seven randomized controlled trials involving 3146 patients met our inclusion criteria. Comparing the results of combination therapy and monotherapy, combination therapy significantly improved OS (RR = 1.13; 95% CI, 1.08, 1.19; P < 0.00001), ORR (RR = 1.36; 95% CI, 1.28, 1.45; P < 0.00001), PFS (RR = 0.57; 95% CI, 0.52, 0.63; P < 0.00001) and reduced deaths (RR = 0.78; 95% CI, 0.69, 0.88; P < 0.0001). Skin-related adverse events such as hyperkeratosis, cutaneous squamous-cell carcinoma were less compared with monoth...Continue Reading

References

Jan 20, 2012·The New England Journal of Medicine·Fei SuRichard Marais
Oct 2, 2012·The New England Journal of Medicine·Keith T FlahertyJeffrey Weber
Mar 15, 2014·F1000Research·Alexandra E Sutton, Roel Lopez
Sep 6, 2014·British Medical Bulletin·Pippa CorrieChristine Parkinson
Sep 18, 2014·Cancer Management and Research·Michael Tronnier, Christina Mitteldorf
Sep 30, 2014·The New England Journal of Medicine·Georgina V LongKeith Flaherty
Sep 30, 2014·The New England Journal of Medicine·James LarkinAntoni Ribas
Nov 18, 2014·The New England Journal of Medicine·Caroline RobertDirk Schadendorf
Nov 21, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A M MenziesA Daud
Jan 1, 2015·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Clement Chung, Sean Reilly
Feb 5, 2015·Expert Opinion on Drug Safety·Lesly A DossettJonathan S Zager
Mar 11, 2015·Therapeutic Advances in Medical Oncology·Sarah J Welsh, Pippa G Corrie
May 23, 2015·Expert Opinion on Pharmacotherapy·Juliet RichmanJames Larkin
Sep 4, 2015·Molecular Cancer Therapeutics·David S HillPenny E Lovat
Nov 1, 2015·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·O Abdel-RahmanH Ahmed
Jan 12, 2016·Therapeutic Advances in Medical Oncology·Zeynep Eroglu, Antoni Ribas
Mar 22, 2016·Expert Opinion on Pharmacotherapy·Amélie Boespflug, Luc Thomas
Feb 9, 2017·Journal of the American Society of Nephrology : JASN·Ewout J Hoorn, Robert Zietse
Oct 21, 2017·Expert Opinion on Drug Safety·Sarah KnispelElisabeth Livingstone
Nov 9, 2017·Annals of Translational Medicine·Imanol Arozarena, Claudia Wellbrock
Jan 25, 2018·Expert Opinion on Drug Metabolism & Toxicology·Elnaz FaghfuriMohammad Abdollahi
Apr 14, 2018·Critical Reviews in Oncology/hematology·Mohd WahidShafiul Haque
Aug 21, 2018·Drug Design, Development and Therapy·Zheng SunXinhai Liu
Aug 28, 2018·Mediators of Inflammation·Kamylla Rafaella Sena AlbuquerqueReggiani Vilela Gonçalves
Sep 7, 2018·Frontiers in Endocrinology·Emilie Jaune, Stéphane Rocchi
Sep 20, 2018·Oncoimmunology·Paolo A Ascierto, Reinhard Dummer
Sep 22, 2018·Lancet·Dirk SchadendorfSelma Ugurel
Nov 22, 2018·Oncotarget·Marta Díaz-MartínezJoaquin Teixidó
Nov 24, 2018·Journal of the European Academy of Dermatology and Venereology : JEADV·N P GrafS M Goldinger
Jan 9, 2019·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal

❮ Previous
Next ❯

Citations

Aug 18, 2020·Assay and Drug Development Technologies·Farrah SollTyler C Moore
Jul 29, 2020·American Journal of Clinical Dermatology·Catherine J Wang, Isaac Brownell
Jun 7, 2021·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Helen GogasKeith T Flaherty
Sep 25, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Érica Aparecida de OliveiraSilvya Stuchi Maria-Engler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.